Valuation: Takeda Pharmaceutical Company Limited

Market Cap 9,21200Cr 5.81TCr 4.99TCr 4.66TCr 4.27TCr 8.03TCr 5,55500Cr 8.16TCr 55TCr 22TCr 2,78600Cr 22TCr 21TCr P/E 2027 *
47.1x
P/E 2028 * 30.1x
Enterprise Value 13,11400Cr 8.27TCr 7.1TCr 6.63TCr 6.08TCr 11TCr 7,90800Cr 12TCr 78TCr 31TCr 3,96600Cr 31TCr 30TCr EV / Sales 2027 *
2.8x
EV / Sales 2028 * 2.71x
Free-Float
99.28%
Yield 2027 *
3.54%
Yield 2028 * 3.61%
1 day+0.69%
1 week+4.50%
Current month+5.37%
1 month+4.57%
3 months+10.54%
6 months+0.33%
Current year+20.14%
1 week 5,504
Extreme 5504
5,840
1 month 5,225
Extreme 5225
5,903
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 56 01/01/2025
Director of Finance/CFO 48 01/04/2024
Chief Tech/Sci/R&D Officer 47 01/02/2022
Director TitleAgeSince
Director/Board Member 60 01/06/2015
Director/Board Member 73 01/01/2019
Director/Board Member 48 01/06/2024
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Sell

Pres., Global Supply & Quality

-20,363 0.0013%
10/08/26 Sell

Pres., Global Supply & Quality

-3,978 0.0002%
10/08/26 Sell

Chief Executive Officer

-89,090 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
+0.68%+4.50%+27.31%+32.38% 5.81TCr
+4.46%+4.92%+82.07%+134.31% 1,14100Cr
+0.85%+4.81%+53.77%+58.51% 66TCr
+2.72%+6.92%+28.99%+77.15% 47TCr
+1.80%+0.52%+41.20%+44.05% 37TCr
+1.24%+2.35%+25.99%+42.21% 30TCr
+2.07%+2.97%+2.27%+13.06% 25TCr
+4.02%+6.29%+49.67%+68.96% 24TCr
+1.05%-0.02%-13.96%-52.13% 21TCr
+2.90%+8.63%+25.11%+94.52% 18TCr
Average +1.80%+4.06%+32.24%+51.30% 38.79TCr
Weighted average by Cap. +1.52%+4.30%+46.76%+73.52%

Financials

2027 *2028 *
Net sales 4,68400Cr 2.96TCr 2.53TCr 2.37TCr 2.17TCr 4.08TCr 2,82400Cr 4.15TCr 28TCr 11TCr 1,41700Cr 11TCr 11TCr 4,75800Cr 3TCr 2.58TCr 2.4TCr 2.21TCr 4.15TCr 2,87000Cr 4.22TCr 28TCr 11TCr 1,43900Cr 11TCr 11TCr
Net income 19TCr 120.3Cr 103.2Cr 96Cr 88Cr 166.25Cr 11TCr 168.99Cr 1.14TCr 445.24Cr 5.77TCr 451.71Cr 441.88Cr 31TCr 197.5Cr 169.42Cr 158.2Cr 145.14Cr 272.94Cr 19TCr 277.43Cr 1.87TCr 730.96Cr 9.47TCr 741.59Cr 725.45Cr
Net Debt 3,90200Cr 2.46TCr 2.11TCr 1.97TCr 1.81TCr 3.4TCr 2,35300Cr 3.46TCr 23TCr 9.11TCr 1,18000Cr 9.24TCr 9.04TCr 3,70100Cr 2.34TCr 2TCr 1.87TCr 1.72TCr 3.23TCr 2,23200Cr 3.28TCr 22TCr 8.64TCr 1,11900Cr 8.77TCr 8.58TCr
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
20/26/20 JP¥5,808.00 +0.68% 33,25,400
19/26/19 JP¥5,769.00 +1.18% 67,79,900
18/26/18 JP¥5,702.00 +3.43% 46,55,200
17/26/17 JP¥5,513.00 -1.75% 25,29,900
14/26/14 JP¥5,611.00 +0.94% 43,76,500
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
5,769.00JPY
Average target price
6,450.19JPY
Spread / Average Target
+11.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock